Cargando…
Oncogenic Network and Hub Genes for Natural Killer/T-Cell Lymphoma Utilizing WGCNA
Natural killer (NK)/T-cell lymphoma (NKTCL) is a subtype of non-Hodgkin lymphoma with aggressive progression and poor prognosis. The molecular mechanisms of NKTCL have not been well-studied. Herein, we revealed the lymphoma-associated dysregulated genes and signaling pathways or biological processes...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066115/ https://www.ncbi.nlm.nih.gov/pubmed/32195177 http://dx.doi.org/10.3389/fonc.2020.00223 |
_version_ | 1783505178355302400 |
---|---|
author | Liu, Huijiao Liu, Mei You, Hua Li, Xiru Li, Xiangdong |
author_facet | Liu, Huijiao Liu, Mei You, Hua Li, Xiru Li, Xiangdong |
author_sort | Liu, Huijiao |
collection | PubMed |
description | Natural killer (NK)/T-cell lymphoma (NKTCL) is a subtype of non-Hodgkin lymphoma with aggressive progression and poor prognosis. The molecular mechanisms of NKTCL have not been well-studied. Herein, we revealed the lymphoma-associated dysregulated genes and signaling pathways or biological processes in NKTCL. We characterized that the extracellular matrix (ECM) receptor interaction pathway and T-cell receptor signaling pathway were the main dysregulated pathways in NKTCL by Gene Ontology (GO) analysis and pathway enrichment analysis. By using weighted gene co-expression network analysis (WGCNA), the gene co-expression network of NKTCL (SRP049695) was constructed, and hub genes (LMO3, GRB14) were identified. In addition, another Gene Expression Omnibus (GEO) dataset (GSE69406) was used to validate these hub genes. Furthermore, these hub genes were identified and validated by survival analysis (GSE90597). These results provided novel insights into the pathogenesis of NKTCL. Of particular interest, LMO3 and GRB14 might be potential oncoproteins and biomarkers for the diagnosis and treatment of NKTCL. |
format | Online Article Text |
id | pubmed-7066115 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-70661152020-03-19 Oncogenic Network and Hub Genes for Natural Killer/T-Cell Lymphoma Utilizing WGCNA Liu, Huijiao Liu, Mei You, Hua Li, Xiru Li, Xiangdong Front Oncol Oncology Natural killer (NK)/T-cell lymphoma (NKTCL) is a subtype of non-Hodgkin lymphoma with aggressive progression and poor prognosis. The molecular mechanisms of NKTCL have not been well-studied. Herein, we revealed the lymphoma-associated dysregulated genes and signaling pathways or biological processes in NKTCL. We characterized that the extracellular matrix (ECM) receptor interaction pathway and T-cell receptor signaling pathway were the main dysregulated pathways in NKTCL by Gene Ontology (GO) analysis and pathway enrichment analysis. By using weighted gene co-expression network analysis (WGCNA), the gene co-expression network of NKTCL (SRP049695) was constructed, and hub genes (LMO3, GRB14) were identified. In addition, another Gene Expression Omnibus (GEO) dataset (GSE69406) was used to validate these hub genes. Furthermore, these hub genes were identified and validated by survival analysis (GSE90597). These results provided novel insights into the pathogenesis of NKTCL. Of particular interest, LMO3 and GRB14 might be potential oncoproteins and biomarkers for the diagnosis and treatment of NKTCL. Frontiers Media S.A. 2020-03-05 /pmc/articles/PMC7066115/ /pubmed/32195177 http://dx.doi.org/10.3389/fonc.2020.00223 Text en Copyright © 2020 Liu, Liu, You, Li and Li. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Liu, Huijiao Liu, Mei You, Hua Li, Xiru Li, Xiangdong Oncogenic Network and Hub Genes for Natural Killer/T-Cell Lymphoma Utilizing WGCNA |
title | Oncogenic Network and Hub Genes for Natural Killer/T-Cell Lymphoma Utilizing WGCNA |
title_full | Oncogenic Network and Hub Genes for Natural Killer/T-Cell Lymphoma Utilizing WGCNA |
title_fullStr | Oncogenic Network and Hub Genes for Natural Killer/T-Cell Lymphoma Utilizing WGCNA |
title_full_unstemmed | Oncogenic Network and Hub Genes for Natural Killer/T-Cell Lymphoma Utilizing WGCNA |
title_short | Oncogenic Network and Hub Genes for Natural Killer/T-Cell Lymphoma Utilizing WGCNA |
title_sort | oncogenic network and hub genes for natural killer/t-cell lymphoma utilizing wgcna |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066115/ https://www.ncbi.nlm.nih.gov/pubmed/32195177 http://dx.doi.org/10.3389/fonc.2020.00223 |
work_keys_str_mv | AT liuhuijiao oncogenicnetworkandhubgenesfornaturalkillertcelllymphomautilizingwgcna AT liumei oncogenicnetworkandhubgenesfornaturalkillertcelllymphomautilizingwgcna AT youhua oncogenicnetworkandhubgenesfornaturalkillertcelllymphomautilizingwgcna AT lixiru oncogenicnetworkandhubgenesfornaturalkillertcelllymphomautilizingwgcna AT lixiangdong oncogenicnetworkandhubgenesfornaturalkillertcelllymphomautilizingwgcna |